58. 肥大型心筋症 Hypertrophic cardiomyopathy Clinical trials / Disease details

臨床試験数 : 119 / 薬物数 : 163 - (DrugBank : 45) / 標的遺伝子数 : 48 - 標的パスウェイ数 : 161

2 trials found

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02948998 (ClinicalTrials.gov)	May 14, 2018	27/10/2016	Evaluating the Effect of Spironolactone on Hypertrophic Cardiomyopathy	Evaluating the Effect of Spironolactoneon Hypertrophic Cardiomyopathy-- a Multicenter Randomized Con ...	Hypertrophic Cardiomyopathy;Fibrosis	Drug: Spironolactone	Xinhua Hospital, Shanghai Jiao Tong University School of Medicine	Ruijin Hospital;RenJi Hospital;Shanghai Jiao Tong University Affiliated Sixth People's Hospital	Unknown status	18 Years	75 Years	All	260	Phase 4	China
2	NCT00879060 (ClinicalTrials.gov)	November 2007	8/4/2009	Clinical and Therapeutic Implications of Fibrosis in Hypertrophic Cardiomyopathy	Clinical and Therapeutic Implications of Fibrosis in Hypertrophic	Myocardial Fibrosis;Hypertrophic Cardiomyopathy	Drug: spironolactone	Tufts Medical Center	NULL	Recruiting	18 Years	70 Years	Both	95	Phase 4	United States

First Previous1Next Last